AstraZeneca hit by generic drugs and Crestor shortfall
LONDON (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscori...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/gyg12OIlAn0/story01.htm
No comments:
Post a Comment